Hematopoietic stem and progenitor cell mobilization in mice and humans by a first-in-class mirror-image oligonucleotide inhibitor of CXCL12

Autor: Werner Purschke, Axel Vater, D Vossmeyer, Stefan Vonhoff, Sven Klussmann, M Lioznov, Klaus Buchner, Christian Maasch, Frank Schwoebel, K Hübel, M Humphrey, Anna Kruschinski, Stefan Zöllner, N Kröger, J Sahlmann, Frank Fliegert
Rok vydání: 2013
Předmět:
Zdroj: Clinical pharmacology and therapeutics. 94(1)
ISSN: 1532-6535
Popis: NOX-A12 is a PEGylated mirror-image oligonucleotide (a so-called Spiegelmer) that binds to CXCL12 (stromal cell–derived factor-1, SDF-1) with high affinity thereby inhibiting CXCL12 signaling on both its receptors, CXCR4 and CXCR7. In animals, NOX-A12 mobilized white blood cells (WBCs) and hematopoietic stem and progenitor cells (HSCs) into peripheral blood (PB). In healthy volunteers, single doses of NOX-A12 had a benign safety profile and also dose-dependently mobilized WBCs and HSCs into PB. HSC peak mobilization reached a plateau at five times the baseline level at an i.v. dose of 5.4 mg/kg. In accordance with the plasma half-life of 38 h, the duration of the WBC and HSC mobilization was long lasting and increased dose-dependently to more than 4 days at the highest dose (10.8 mg/kg). In conclusion, NOX-A12 may be appropriate for therapeutic use in and beyond mobilization of HSCs, e.g., in long-lasting mobilization and chemosensitization of hematological cancer cells. Clinical Pharmacology & Therapeutics (2013); 94 1, 150–157. doi:10.1038/clpt.2013.58
Databáze: OpenAIRE